Close Menu

NEW YORK (GenomeWeb) – OmniSeq and Laboratory Corporation of America have extended their exclusive distribution agreement for OmniSeq's immune profiling and pan-cancer next-generation sequencing tests the companies signed in 2017.

As part of the expanded deal, LabCorp will distribute OmniSeq's Advance and OmniSeq MSI NGS tests. The original deal covered the OmniSeq Comprehensive and Immune Report Card clinical assays.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.